Affymax, Inc. (Nasdaq: AFFY) will host a teleconference and webcast at 5:30 a.m. Pacific Time; 8:30 a.m. Eastern Time today, February 25, to discuss the voluntary recall of OMONTYS® (peginesatide) Injection. Interested parties can listen to the live teleconference by dialing (866) 393-1565 from the U.S. or +1(973) 409-9608 for international callers. Individuals may access the live audio webcast by visiting www.affymax.com and going to the Investors section. A replay of the webcast will be available on the company’s website for 30 days following the live event. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. For additional information on Affymax, please visit www.affymax.com.